FRIEDREICH'S ATAXIA
Clinical trials for FRIEDREICH'S ATAXIA explained in plain language.
Never miss a new study
Get alerted when new FRIEDREICH'S ATAXIA trials appear
Sign up with your email to follow new studies for FRIEDREICH'S ATAXIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug aims to halt rare neurological decline
Disease control Not yet recruitingThis Phase 3 trial tests whether vatiquinone can slow the progression of Friedreich's ataxia, a rare genetic disorder that damages the nervous system and impairs movement. About 120 adults with moderate symptoms will take the drug for 24 months. Researchers will measure changes i…
Matched conditions: FRIEDREICH'S ATAXIA
Phase: PHASE3 • Sponsor: PTC Therapeutics • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Exercise and drug combo may fight fatigue in rare disease
Symptom relief Not yet recruitingThis study looks at whether doing aerobic exercise at home, with or without the drug omaveloxolone, can safely improve fatigue and heart-lung fitness in people with Friedreich's ataxia. About 30 adults with the condition will take part. The goal is to see if the combination helps…
Matched conditions: FRIEDREICH'S ATAXIA
Phase: NA • Sponsor: Scott Barbuto • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC